234 related articles for article (PubMed ID: 19010906)
21. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation.
Brüning A; Rahmeh M; Friese K
Mol Oncol; 2013 Dec; 7(6):1012-8. PubMed ID: 23916134
[TBL] [Abstract][Full Text] [Related]
22. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis.
Nawrocki ST; Carew JS; Pino MS; Highshaw RA; Dunner K; Huang P; Abbruzzese JL; McConkey DJ
Cancer Res; 2005 Dec; 65(24):11658-66. PubMed ID: 16357177
[TBL] [Abstract][Full Text] [Related]
23. Preferential cytotoxicity of bortezomib toward highly malignant human liposarcoma cells via suppression of MDR1 expression and function.
Hu Y; Wang L; Wang L; Wu X; Wu X; Gu Y; Shu Y; Sun Y; Shen Y; Xu Q
Toxicol Appl Pharmacol; 2015 Feb; 283(1):1-8. PubMed ID: 25576094
[TBL] [Abstract][Full Text] [Related]
24. Targeting endoplasmic reticulum signaling pathways in cancer.
Martinon F
Acta Oncol; 2012 Sep; 51(7):822-30. PubMed ID: 22686473
[TBL] [Abstract][Full Text] [Related]
25. Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.
Shirley CM; Chen J; Shamay M; Li H; Zahnow CA; Hayward SD; Ambinder RF
Blood; 2011 Jun; 117(23):6297-303. PubMed ID: 21447826
[TBL] [Abstract][Full Text] [Related]
26. Cell death induced by the ER stressor thapsigargin involves death receptor 5, a non-autophagic function of MAP1LC3B, and distinct contributions from unfolded protein response components.
Lindner P; Christensen SB; Nissen P; Møller JV; Engedal N
Cell Commun Signal; 2020 Jan; 18(1):12. PubMed ID: 31987044
[TBL] [Abstract][Full Text] [Related]
27. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
Birle DC; Hedley DW
Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
[TBL] [Abstract][Full Text] [Related]
28. Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells.
Cheng Y; Ren X; Zhang Y; Shan Y; Huber-Keener KJ; Zhang L; Kimball SR; Harvey H; Jefferson LS; Yang JM
Autophagy; 2013 Feb; 9(2):208-19. PubMed ID: 23182879
[TBL] [Abstract][Full Text] [Related]
29. Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells.
Moriya S; Che XF; Komatsu S; Abe A; Kawaguchi T; Gotoh A; Inazu M; Tomoda A; Miyazawa K
Int J Oncol; 2013 May; 42(5):1541-50. PubMed ID: 23546223
[TBL] [Abstract][Full Text] [Related]
30. Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma.
Weniger MA; Rizzatti EG; Pérez-Galán P; Liu D; Wang Q; Munson PJ; Raghavachari N; White T; Tweito MM; Dunleavy K; Ye Y; Wilson WH; Wiestner A
Clin Cancer Res; 2011 Aug; 17(15):5101-12. PubMed ID: 21712452
[TBL] [Abstract][Full Text] [Related]
31. Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells.
Meister S; Frey B; Lang VR; Gaipl US; Schett G; Schlötzer-Schrehardt U; Voll RE
Neoplasia; 2010 Jul; 12(7):550-61. PubMed ID: 20651984
[TBL] [Abstract][Full Text] [Related]
32. Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells.
Selimovic D; Porzig BB; El-Khattouti A; Badura HE; Ahmad M; Ghanjati F; Santourlidis S; Haikel Y; Hassan M
Cell Signal; 2013 Jan; 25(1):308-18. PubMed ID: 23079083
[TBL] [Abstract][Full Text] [Related]
33. The unfolded protein response selectively targets active smoothened mutants.
Marada S; Stewart DP; Bodeen WJ; Han YG; Ogden SK
Mol Cell Biol; 2013 Jun; 33(12):2375-87. PubMed ID: 23572559
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines.
Landowski TH; Megli CJ; Nullmeyer KD; Lynch RM; Dorr RT
Cancer Res; 2005 May; 65(9):3828-36. PubMed ID: 15867381
[TBL] [Abstract][Full Text] [Related]
35. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
[TBL] [Abstract][Full Text] [Related]
36. Fold up or perish: unfolded protein response and chemotherapy.
Strasser A; Puthalakath H
Cell Death Differ; 2008 Feb; 15(2):223-5. PubMed ID: 18049478
[No Abstract] [Full Text] [Related]
37. Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways.
Yu C; Friday BB; Lai JP; Yang L; Sarkaria J; Kay NE; Carter CA; Roberts LR; Kaufmann SH; Adjei AA
Mol Cancer Ther; 2006 Sep; 5(9):2378-87. PubMed ID: 16985072
[TBL] [Abstract][Full Text] [Related]
38. Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.
Ri M; Iida S; Nakashima T; Miyazaki H; Mori F; Ito A; Inagaki A; Kusumoto S; Ishida T; Komatsu H; Shiotsu Y; Ueda R
Leukemia; 2010 Aug; 24(8):1506-12. PubMed ID: 20555361
[TBL] [Abstract][Full Text] [Related]
39. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
40. JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways.
Lauricella M; Emanuele S; D'Anneo A; Calvaruso G; Vassallo B; Carlisi D; Portanova P; Vento R; Tesoriere G
Apoptosis; 2006 Apr; 11(4):607-25. PubMed ID: 16528474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
